179 related articles for article (PubMed ID: 1900989)
1. 2,3-di-O-tetradecyl-1-O-(beta-D-glucopyranosyl)-sn-glycerol is a substrate for human glucocerebrosidase.
Glew RH; Gopalan V; Hubbell CA; Devraj RV; Lawson RA; Diven WF; Mannock DA
Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):557-63. PubMed ID: 1900989
[TBL] [Abstract][Full Text] [Related]
2. Brain glucocerebrosidase in Gaucher's disease.
Daniels LB; Coyle PJ; Glew RH; Radin NS; Labow RS
Arch Neurol; 1982 Sep; 39(9):550-6. PubMed ID: 6810854
[TBL] [Abstract][Full Text] [Related]
3. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
Glew RH; Daniels LB; Clark LS; Hoyer SW
J Neuropathol Exp Neurol; 1982 Nov; 41(6):630-41. PubMed ID: 6813430
[TBL] [Abstract][Full Text] [Related]
4. A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.
Daniels LB; Glew RH; Radin NS; Vunnam RR
Clin Chim Acta; 1980 Sep; 106(2):155-63. PubMed ID: 6773704
[TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of a cytosolic broad specificity beta-glucosidase from human liver.
Daniels LB; Coyle PJ; Chiao YB; Glew RH; Labow RS
J Biol Chem; 1981 Dec; 256(24):13004-13. PubMed ID: 6796580
[TBL] [Abstract][Full Text] [Related]
6. Gaucher's disease.
Patel AL; Shaikh WA; Khobragade AK; Soni HG; Joshi AS; Sahasrabudhe GS; Chole PV
J Assoc Physicians India; 2009 May; 57():410-1. PubMed ID: 19634291
[TBL] [Abstract][Full Text] [Related]
7. Comparison of rates of hydrolysis of N-oleoyl and N-stearoyl glucocerebroside in patients with Gaucher's disease.
Peters SP; Aquino L; Naccarato WF; Gilbertson JR; Diven WF; Glew RH
Biochim Biophys Acta; 1979 Oct; 575(1):27-36. PubMed ID: 508779
[TBL] [Abstract][Full Text] [Related]
8. Effect of a heat-stable factor in human placenta on glucosylceramidase, glucosylsphingosine glucosyl hydrolase, and acid beta-glucosidase activities.
Vaccaro AM; Muscillo M; Tatti M; Salvioli R; Gallozzi E; Suzuki K
Clin Biochem; 1987 Dec; 20(6):429-33. PubMed ID: 3124976
[TBL] [Abstract][Full Text] [Related]
9. Animal and cellular models of Gaucher's disease. I. Refractoriness of thio analogs of glucocerebroside to enzymatic hydrolysis.
Quirk JM; Weis AL; Shapiro D; Brady RO
Biotechnol Appl Biochem; 1986 Feb; 8(1):96-100. PubMed ID: 3828086
[TBL] [Abstract][Full Text] [Related]
10. Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.
Basu A; Glew RH; Daniels LB; Clark LS
J Biol Chem; 1984 Feb; 259(3):1714-9. PubMed ID: 6693432
[TBL] [Abstract][Full Text] [Related]
11. [Preclinical research of a new therapy for Gaucher's disease with F213I mutation].
Hou L; Kousaku O
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):381-4. PubMed ID: 14556188
[TBL] [Abstract][Full Text] [Related]
12. Human glucocerebrosidase catalyses transglucosylation between glucocerebroside and retinol.
Vanderjagt DJ; Fry DE; Glew RH
Biochem J; 1994 Jun; 300 ( Pt 2)(Pt 2):309-15. PubMed ID: 8002933
[TBL] [Abstract][Full Text] [Related]
13. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
Gatt S; Dinur T; Osiecki K; Desnick RJ; Grabowski GA
Enzyme; 1985; 33(2):109-19. PubMed ID: 3924590
[TBL] [Abstract][Full Text] [Related]
14. Use of 4-heptylumbelliferyl-beta-D-glucoside to identify Gaucher's disease heterozygotes.
Butcher BA; Gopalan V; Lee RE; Richards TC; Waggoner AS; Glew RH
Clin Chim Acta; 1989 Oct; 184(3):235-42. PubMed ID: 2515009
[TBL] [Abstract][Full Text] [Related]
15. A kinetic study of the effects of galactocerebroside 3-sulphate on human spleen glucocerebrosidase. Evidence for two activator-binding sites.
Prence EM; Garrett KO; Glew RH
Biochem J; 1986 Aug; 237(3):655-62. PubMed ID: 3800908
[TBL] [Abstract][Full Text] [Related]
16. Human acid beta-glucosidase: inhibition studies using glucose analogues and pH variation to characterize the normal and Gaucher disease glycon binding sites.
Osiecki-Newman K; Legler G; Grace M; Dinur T; Gatt S; Desnick RJ; Grabowski GA
Enzyme; 1988; 40(4):173-88. PubMed ID: 3234317
[TBL] [Abstract][Full Text] [Related]
17. The occurrence of two immunologically distinguishable beta-glucocerebrosidases in human spleen.
Aerts JM; Donker-Koopman WE; van der Vliet MK; Jonsson LM; Ginns EI; Murray GJ; Barranger JA; Tager JM; Schram AW
Eur J Biochem; 1985 Aug; 150(3):565-74. PubMed ID: 4018098
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the phospholipid requirement of a rat liver beta-glucosidase.
Basu A; Glew RH
Biochem J; 1984 Dec; 224(2):515-24. PubMed ID: 6517862
[TBL] [Abstract][Full Text] [Related]
19. The enzymatic hydrolysis of 6-acylamino-4-methylumbelliferyl-beta-D-glucosides: identification of a novel human acid beta-glucosidase.
Mikhaylova M; Wiederschain G; Mikhaylov V; Aerts JM
Biochim Biophys Acta; 1996 Oct; 1317(1):71-9. PubMed ID: 8876629
[TBL] [Abstract][Full Text] [Related]
20. Activation of human spleen glucocerebrosidases by monoacylglycol sulfates and diacylglycerol sulfates.
Gonzales ML; Basu A; de Haas GH; Dijkman R; van Oort MG; Okolo AA; Glew RH
Arch Biochem Biophys; 1988 Apr; 262(1):345-53. PubMed ID: 3355173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
